Medication info
Neomaril Tablet 2 mg (Glimepiride)

Neomaril Tablet 2 mg (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Green oval tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200300104 · Notified 2003.11.13 · Insurance code 643300150

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing, with at least 1/2 cup of water. Take this medicine orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1–2 weeks. In general, there is little additional benefit with doses greater than 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve as treatment progresses, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral antihyperglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this medicine, it is advisable to follow the instructions given under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1–2-week intervals. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose monitoring Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine; regular measurement of glycosylated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite initially successful management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood sugar control issues in patients with type 2 diabetes
View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It can be administered alone or in combination with other medications, alongside dietary and exercise therapy. This helps in effectively managing blood sugar levels.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing, with at least 1/2 cup of water. Take this medicine orally once daily. Take it before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1–2 weeks. In general, there is little additional benefit with doses greater than 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve as treatment progresses, the need for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered in the event of weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia. 3) Switching from another oral antihyperglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this medicine, it is advisable to follow the instructions given under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1–2-week intervals. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose monitoring Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine; regular measurement of glycosylated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur despite initially successful management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure, and should be used when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or diabetic ketoacidosis, or in patients who are in a coma. It should also not be given to people who are allergic to this medication or sulfonylurea drugs, or in patients with severe liver or kidney dysfunction. Pregnant or breastfeeding women should not use this medication. In patients with severe infections, post-operative conditions, or severe trauma, insulin treatment is recommended, and this medication should be avoided. Patients with gastrointestinal disorders should be cautious as food absorption may be unstable, increasing the risk of hypoglycemia. This medication contains lactose, so it should not be taken by patients with lactose intolerance or galactose absorption disorders. During initial dosing, there is a high risk of hypoglycemia, so special caution is necessary in cases of irregular meals, poor nutritional status, alcohol consumption, kidney or liver dysfunction, or in elderly patients. Symptoms of hypoglycemia include headache, severe hunger, nausea, fatigue, anxiety, confusion, dizziness, drowsiness, and loss of consciousness, and immediate action should be taken if these symptoms occur. While taking this medication, blurred vision, dyspepsia, abnormal liver function, blood abnormalities, and allergic reactions may occur, so any unusual symptoms should be reported to a doctor. It is very important to combine dietary and exercise therapy for blood sugar control, and to immediately consume sugar if hypoglycemia occurs. If taken with other drugs, interactions may occur, so be sure to inform your doctor or pharmacist of any medications being taken. If pregnant or breastfeeding, it is advisable to switch to insulin therapy as this medication may be harmful to the fetus or newborn. In the case of overdose, hypoglycemia may worsen, and immediate medical treatment should be sought. This medication should be stored out of reach of children.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language disturbance, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cool and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, a feeling of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, abnormal liver function, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, abnormal liver function, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a closed container to protect it from air or moisture. It is best to maintain storage temperatures between 1°C and 30°C.

Appearance and packaging

Appearance

Green oval tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.